59 related articles for article (PubMed ID: 11828716)
1. Protective effects of cannabinoid receptor ligands analogous to anandamide against cocaine toxicity.
Hayase T; Yamamoto Y; Yamamoto K
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2001 Dec; 36(6):596-608. PubMed ID: 11828716
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of cannabinoid receptor agonists against cocaine and other convulsant-induced toxic behavioural symptoms.
Hayase T; Yamamoto Y; Yamamoto K
J Pharm Pharmacol; 2001 Nov; 53(11):1525-32. PubMed ID: 11732755
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1).
Hillard CJ; Manna S; Greenberg MJ; DiCamelli R; Ross RA; Stevenson LA; Murphy V; Pertwee RG; Campbell WB
J Pharmacol Exp Ther; 1999 Jun; 289(3):1427-33. PubMed ID: 10336536
[TBL] [Abstract][Full Text] [Related]
4. Persistent anxiogenic effects of a single or repeated doses of cocaine and methamphetamine: interactions with endogenous cannabinoid receptor ligands.
Hayase T; Yamamoto Y; Yamamoto K
Behav Pharmacol; 2005 Sep; 16(5-6):395-404. PubMed ID: 16148444
[TBL] [Abstract][Full Text] [Related]
5. Effect of ACEA--a selective cannabinoid CB1 receptor agonist on the protective action of different antiepileptic drugs in the mouse pentylenetetrazole-induced seizure model.
Andres-Mach M; Zolkowska D; Barcicka-Klosowska B; Haratym-Maj A; Florek-Luszczki M; Luszczki JJ
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):301-9. PubMed ID: 22789660
[TBL] [Abstract][Full Text] [Related]
6. Arachidonyl-2'-chloroethylamide, a highly selective cannabinoid CB1 receptor agonist, enhances the anticonvulsant action of valproate in the mouse maximal electroshock-induced seizure model.
Luszczki JJ; Czuczwar P; Cioczek-Czuczwar A; Czuczwar SJ
Eur J Pharmacol; 2006 Oct; 547(1-3):65-74. PubMed ID: 16930590
[TBL] [Abstract][Full Text] [Related]
7. N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo.
Bisogno T; Melck D; Bobrov MYu ; Gretskaya NM; Bezuglov VV; De Petrocellis L; Di Marzo V
Biochem J; 2000 Nov; 351 Pt 3(Pt 3):817-24. PubMed ID: 11042139
[TBL] [Abstract][Full Text] [Related]
8. Effect of arachidonyl-2'-chloroethylamide, a selective cannabinoid CB1 receptor agonist, on the protective action of the various antiepileptic drugs in the mouse maximal electroshock-induced seizure model.
Luszczki JJ; Czuczwar P; Cioczek-Czuczwar A; Dudra-Jastrzebska M; Andres-Mach M; Czuczwar SJ
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):18-25. PubMed ID: 19751793
[TBL] [Abstract][Full Text] [Related]
9. Anandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neurons.
Roberts LA; Christie MJ; Connor M
Br J Pharmacol; 2002 Oct; 137(4):421-8. PubMed ID: 12359623
[TBL] [Abstract][Full Text] [Related]
10. Evidence of a novel site mediating anandamide-induced negative inotropic and coronary vasodilatator responses in rat isolated hearts.
Ford WR; Honan SA; White R; Hiley CR
Br J Pharmacol; 2002 Mar; 135(5):1191-8. PubMed ID: 11877326
[TBL] [Abstract][Full Text] [Related]
11. Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors.
Priller J; Briley EM; Mansouri J; Devane WA; Mackie K; Felder CC
Mol Pharmacol; 1995 Aug; 48(2):288-92. PubMed ID: 7651362
[TBL] [Abstract][Full Text] [Related]
12. Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain.
Adams IB; Compton DR; Martin BR
J Pharmacol Exp Ther; 1998 Mar; 284(3):1209-17. PubMed ID: 9495885
[TBL] [Abstract][Full Text] [Related]
13. Influence of arachidonyl-2'-chloroethylamide, a selective cannabinoid CB1 receptor agonist, on the anticonvulsant and acute side-effect potentials of clobazam, lacosamide, and pregabalin in the maximal electroshock-induced seizure model and chimney test in mice.
Florek-Luszczki M; Zagaja M; Luszczki JJ
Fundam Clin Pharmacol; 2015 Aug; 29(4):382-93. PubMed ID: 25904357
[TBL] [Abstract][Full Text] [Related]
14. Stress-related behavioral alterations accompanying cocaine toxicity: the effects of mixed opioid drugs.
Hayase T; Yamamoto Y; Yamamoto K
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2000 Dec; 35(6):402-14. PubMed ID: 11197874
[TBL] [Abstract][Full Text] [Related]
15. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide.
Gonsiorek W; Lunn C; Fan X; Narula S; Lundell D; Hipkin RW
Mol Pharmacol; 2000 May; 57(5):1045-50. PubMed ID: 10779390
[TBL] [Abstract][Full Text] [Related]
16. Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth.
Bifulco M; Laezza C; Portella G; Vitale M; Orlando P; De Petrocellis L; Di Marzo V
FASEB J; 2001 Dec; 15(14):2745-7. PubMed ID: 11687506
[TBL] [Abstract][Full Text] [Related]
17. Effects of ethanol and/or cardiovascular drugs on cocaine- and methamphetamine-induced fatal toxicities in mice.
Hayase T; Yamamoto Y; Yamamoto K; Abiru H; Nishitani Y; Fukui Y
Nihon Arukoru Yakubutsu Igakkai Zasshi; 1999 Oct; 34(5):475-90. PubMed ID: 10565158
[TBL] [Abstract][Full Text] [Related]
18. Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures.
Molina-Holgado F; Molina-Holgado E; Guaza C; Rothwell NJ
J Neurosci Res; 2002 Mar; 67(6):829-36. PubMed ID: 11891798
[TBL] [Abstract][Full Text] [Related]
19. Antidotal effects of buprenorphine on the behavioral alterations accompanying cocaine and combined cocaine-ethanol toxicity.
Hayase T; Yamamoto Y; Yamamoto K
Pharmacol Biochem Behav; 2002; 71(1-2):19-27. PubMed ID: 11812504
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic-pharmacodynamic influence of N-palmitoylethanolamine, arachidonyl-2'-chloroethylamide and WIN 55,212-2 on the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice.
Citraro R; Russo E; Leo A; Russo R; Avagliano C; Navarra M; Calignano A; De Sarro G
Eur J Pharmacol; 2016 Nov; 791():523-534. PubMed ID: 27663280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
